Related Experiment Video
Updated: Jun 20, 2026
06:52
Detection of Inflammasome Activation and Pyroptotic Cell Death in Murine Bone Marrow-derived Macrophages
Published on: May 21, 2018
Dysfunctional inflammasome in Schnitzler's syndrome
Cinzia Pizzirani1, Simonetta Falzoni, Marcello Govoni
1Department of Experimental and Diagnostic Medicine, Section of General Pathology, University of Ferrara, Ferrara, Italy.
Rheumatology (Oxford, England)
|August 22, 2009
Summary
Inflammasome activity in Schnitzler's syndrome (SS) involves abnormal interleukin-1 beta (IL-1beta) release. Steroid therapy normalized IL-1beta secretion and inflammasome component expression in SS patients.
Area of Science:
- Immunology
- Molecular Biology
- Rheumatology
Background:
- Schnitzler's syndrome (SS) is characterized by the key role of interleukin-1 beta (IL-1beta) in its pathogenesis.
- Investigating inflammasome activity in peripheral blood mononuclear cells (PBMCs) is crucial for understanding SS variants.
Observation:
- PBMCs from an SS patient exhibited high spontaneous and stimulated IL-1beta release.
- P2X7 receptor expression was elevated, while ASC expression was reduced in SS patient PBMCs compared to controls.
- NLRP3 expression remained unchanged, and the response to P2X7 agonist was diminished.
Findings:
- SS PBMCs show dysregulated inflammasome activity with aberrant IL-1beta processing and release.
- Prednisone treatment effectively reduced clinical symptoms and normalized IL-1beta secretion and inflammasome component expression (P2X7, ASC).
Implications:
- These findings highlight a systemic inflammasome derangement in Schnitzler's syndrome.
- Targeting inflammasome pathways, particularly IL-1beta, may offer therapeutic strategies for SS.
- Understanding these mechanisms can guide treatment for rare autoinflammatory diseases.
Related Concept Videos
01:25Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
01:12Chronic Inflammation: Introduction
Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
01:20Inflammatory Bowel Disease II: Ulcerative Colitis
Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
01:30Inflammatory Bowel Disease II: Crohn's Disease
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...